...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Additional Exempt Distribution- 2023-03-31
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Hong Kong puts out the biggest buck (~$6M) in the last two Exempt Distributions and gets warrants that expire Nov 2023 ....... What don't we know?

Let's hope something is cooking in the Zenith kitchen.

 

Koo

4 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply